Multitargeted therapy of ABT-450 with ritonavir, ombitasvir and dasabuvir yielded strong response rates with...
Read More
A drug combination with striking efficacy in relatively healthy hepatitis C (HCV) patients had...
UT Medicine San Antonio & Texas Liver Institute Researchers Cure 90% of Studied Hepatitis C Patients
An international study including researchers from University of Texas Medicine San Antonio and Texas Liver...
Oral combination proves safe for patients who could not have interferon therapy SAN ANTONIO,...
An experimental trial of two drugs in one pill had a high cure rate...